Nucleic acid synthesis techniques

US12416048B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12416048-B2
Application numberUS-201916704190-A
CountryUS
Kind codeB2
Filing dateDec 5, 2019
Priority dateMay 16, 2014
Publication dateSep 16, 2025
Grant dateSep 16, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for synthesizing a nucleic acid includes synthesizing one or more nucleic acid fragments on a substrate. The synthesized one or more nucleic acid fragments may be amplified on the substrate. The method also includes sequencing the synthesized or amplified one or more nucleic acid fragments on the substrate. The sequencing may provide feedback to designs of the one or more nucleic acid fragments. The method further includes harvesting the synthesized or amplified one or more nucleic acid fragments based on sequencing. The synthesized or amplified one or more nucleic acid fragments may be assembled to generate a target nucleic acid.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for synthesizing a nucleic acid, comprising: (a) a synthesis substrate comprising a plurality of flow channels, each of the plurality of flow channels (i) comprising a plurality of immobilized primer oligonucleotides and (ii) lacking a template nucleic acid complementary to the plurality of immobilized primer oligonucleotides; (b) a processor-based device storing executable instructions and coupled to the synthesis substrate, wherein the executable instructions are configured to: (i) receive one or more synthesis signals for each respective flow channel indicative of a presence of a first polymerase extending de novo the plurality of immobilized primer oligonucleotides in the absence of the template nucleic acid to generate a respective plurality of single-stranded fragment polynucleotides based on one of a plurality of target sequences; (ii) control entry of a first sequencing reagent, a second sequencing reagent, and a second polymerase into the flow channels based on the one or more synthesis signals, wherein the first sequencing reagent comprises one or more nucleotide monomers, wherein the one or more nucleotide monomers form a plurality of polynucleotides complementary to at least a portion of the plurality of fragment polynucleotides, wherein the second sequencing reagent comprises at least one nucleotide monomer, and wherein the at least one nucleotide monomer of the second sequencing reagent comprises a reversibly terminating moiety; iii) receive one or more sequencing signals for each respective flow channel indicative of a presence of the first sequencing reagent and the second sequencing reagent in the presence of the second polymerase; (iv) determine a sequence of each of the plurality of fragment polynucleotides based on the one or more sequencing signals; and (v) provide an indication related to a comparison of the sequence of each of the plurality of fragment polynucleotides with the respective target sequence; (c) an assembly cell comprising an assembly substrate comprising an immobilized anchor oligonucleotide, wherein the assembly cell is configured to gather each of the plurality of fragment polynucleotides from each of the plurality of flow channels and assemble each of the plurality of fragment polynucleotides to generate an assembled polynucleotide; and (d) the assembled polynucleotide, wherein the assembled polynucleotide comprises double-stranded regions and single-stranded gaps regions, wherein the single-stranded regions are in both strands, and wherein the assembled polynucleotide is immobilized on the assembly substrate via the immobilized anchor oligonucleotide. 2. The system of claim 1 , wherein each of the plurality of flow channels is configured to immobilize a plurality of amplification oligonucleotides on the synthesis substrate, and wherein the executable instructions further comprise instructions to amplify the plurality of fragment polynucleotides by annealing the fragment polynucleotides to one or more of the plurality of immobilized amplification oligonucleotides. 3. The system of claim 1 , wherein the executable instructions further comprise instructions to amplify the assembled polynucleotide by annealing to one or more of a plurality of immobilized amplification oligonucleotides in the assembly cell. 4. The system of claim 1 , wherein the executable instructions further comprise instructions to receive a third sequencing reagent at the assembly cell in the presence of a third polymerase and to receive a fourth sequencing reagent, wherein the third sequencing reagent comprises one or more nucleotide monomers, wherein the one or more nucleotide monomers form a plurality of polynucleotides complementary to at least a portion of the assembled polynucleotide, wherein the fourth sequencing reagent comprises at least one nucleotide monomer, wherein the at least one nucleotide monomer of the fourth sequencing reagent comprises a reversibly terminating moiety, and wherein the fourth sequencing reagent is provided subsequent to providing the third sequencing reagent, whereby sequence information for the assembled polynucleotide is obtained. 5. The system of claim 1 , wherein the executable instructions further comprise instructions to harvest the plurality of fragment polynucleotides if the sequence of each of the plurality of fragment polynucleotides is identified to include the respective target sequence or to be complementary to the respective target sequence. 6. The system of claim 5 , wherein the executable instructions further comprise instructions to harvest the plurality of fragment polynucleotides if the sequence of each of the plurality of fragment polynucleotides has a sequence error rate less than a predetermined threshold. 7. The system of claim 1 , wherein the executable instructions further comprise instructions to harvest the plurality of fragment polynucleotides by cleaving the plurality of fragment polynucleotides from the plurality of primer oligonucleotides. 8. The system of claim 1 , comprising a processor configured to generate a sequence accuracy score or metric for each of the plurality of fragment polynucleotides. 9. The system of claim 1 , wherein the first polymerase comprises terminal deoxynucleotidyl transferase (TdT). 10. The system of claim 1 , wherein the synthesis substrate comprises a bead, a magnetic bead, a glass slide, a microchip, a nano droplet, an electrowetting cartridge, or any combination thereof. 11. The system of claim 1 , wherein the plurality of immobilized primer oligonucleotides comprises a cleavable linker. 12. The system of claim 1 , wherein the respective plurality of single-stranded fragment polynucleotides based on one of a plurality of target sequences comprises a plurality of overlapping nucleic acid fragments having complementary portions to at least one other fragment of the nucleic acid fragments. 13. The system of claim 12 , wherein the plurality of immobilized primer oligonucleotides further comprises the respective plurality of single-stranded fragment polynucleotides based on one of a plurality of target sequences. 14. The system of claim 12 , wherein the assembly cell further comprises the respective plurality of single-stranded fragment polynucleotides based on one of a plurality of target sequences. 15. The system of claim 12 , wherein the plurality of target sequences comprises a first end sequence, a second end sequence, and an intermediate sequence therebetween, wherein the plurality of overlapping nucleic acid fragments comprises a first fragment comprising a portion having the first end sequence, and wherein the assembled polynucleotide is immobilized on the assembly substrate via hybridization of the first fragment with the immobilized anchor oligonucleotide. 16. The system of claim 15 , wherein an end of the first fragment comprises a cleavable adapter. 17. The system of claim 1 , wherein the assembly substrate comprises a plurality of immobilized amplification oligonucleotides. 18. The system of claim 17 , further comprising a solution in contact with the assembly substrate, wherein the solution comprises reagents suitable for performing bridge amplification. 19. The system of claim 1 , further comprising a solution in contact with the assembly substrate, wherein the solution comprises reagents suitable for gap repair. 20. A system for synthesizing a nucleic acid, comprising: (a) a synthesis substrate comprising a plurality of flow channels, each of the plurality of flow channels (i) com

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12416048B2 cover?
A method for synthesizing a nucleic acid includes synthesizing one or more nucleic acid fragments on a substrate. The synthesized one or more nucleic acid fragments may be amplified on the substrate. The method also includes sequencing the synthesized or amplified one or more nucleic acid fragments on the substrate. The sequencing may provide feedback to designs of the one or more nucleic acid …
Who is the assignee on this patent?
Illumina Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6874. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).